According to a market report by Lucintel, the future of the antidepressant market in Germany looks promising with opportunities in the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder markets. The global antidepressant market is expected to reach an estimated $21.8 billion by 2031 with a CAGR of 5.3% from 2025 to 2031. The antidepressant market in Germany is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the rising prevalence of depression, obsessive-compulsive disorder, and other mood disorders across the globe and growing awareness about mental health.
A more than 150-page report to understand trends, opportunity and forecast in antidepressant market in Germany to 2031 by product (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist & reuptake inhibitors, and others), and depressive disorder (major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others)
Download sample by clicking on antidepressant market in Germany
Lucintel forecasts that, within the product category, the selective serotonin reuptake inhibitor will remain the largest segment over the forecast period due to the rising occurrence of major depressive disorder and anxiety disorders.
Within the depressive disorder category, major depressive disorder will remain the largest segment due to the high prevalence of major depressive disorder and increasing awareness towards treatment and management of depression among the youth population.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Antidepressant Market in Italy
Antidepressant Market in Netherlands
Antidepressant Market in Spain
Antidepressant Market in Turkey
Antidepressant Market in United Kingdom